Dawnrays Pharmaceutical (02348) Reports Increase in Issued Shares and Maintains Public Float Compliance for January 2026
Bulletin Express
Feb 03
Dawnrays Pharmaceutical (Holdings) Limited reported an unchanged authorized share capital of HKD 1,000,000,000, comprising 20,000,000,000 ordinary shares at HKD 0.05 par value each, as of January 31, 2026. The total issued shares rose by 200,000 from the prior month to reach 1,503,557,000 shares. This increase stemmed from the exercise of share options under the 2013 Share Option Scheme, which generated proceeds of HKD 180,000. The company confirmed that it continues to meet the applicable public float threshold under relevant listing requirements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.